17 March 2026 in Proceedings of the National Academy of Sciences
The brain operates at the critical transition between order and disorder which supports optimal information processing. Whole-brain computational modeling is a powerful tool for uncovering the system-level mechanisms behind large-scale brain activity in both healthy and pathological states. However, most previous approaches have focused on either functional connectivity or criticality, making it difficult to capture both aspects simultaneously. Here, we introduce a method based on a Hierarchical Kuramoto model that incorporates two levels of hierarchy. In our model, each node contains a large number of coupled oscillators, which allows us to examine both local synchronization and long-distance interactions between brain regions. The model produces critical-like dynamics marked by emergent long-range temporal correlations (LRTCs) and both interareal phase synchronization and amplitude cross-correlations (CC) during the transition from asynchronous to synchronous states. Notably, structure–function coupling shows distinct patterns: correlations with structural connectivity peak at criticality for LRTCs and CC, but decay for local and interareal phase synchronization. Comparisons with human resting-state magnetoencephalography (MEG) data reveal that the model’s behavior most closely resembles MEG phase synchronization and multipeak power spectra on the subcritical side of an extended critical regime, supporting the hypothesis that the human brain operates in this state.
25 May 2025 in Digital Health
Background: Digital intervention safety is crucial for regulatory approval and clinical adoption. However, the evaluation and reporting of adverse events (AEs) in clinical trials are often insufficient. Digital qualitative self-reporting could enhance the detection of AEs, but patient preferences for using such channels remain understudied. Methods: This observational study was conducted in Finland between 2022 and 2024 within a randomized controlled trial evaluating the efficacy of Meliora , a game-based digital intervention for patients living with major depressive disorder. We assessed the preferences of 1001 patients for self-reporting AEs across four channels: a prompted, within-intervention questionnaire (CORTO: Contextual, One-item, Repeated, Timely, Open-ended), a Jira questionnaire, email, and phone. Results: 148 (14.8%) patients reported AEs during the study. We found a significant imbalance between the channels: 11.3% ( n = 113) of patients reported AEs using CORTO, 4.1% ( n = 41) using email, 1.1% ( n = 11) using Jira, and 0.4% ( n = 4) using phone. Conclusions: These findings reveal that patients prefer low-effort methods for reporting AEs and are more likely to report AEs via a prompted, within-intervention questionnaire (CORTO) than through other methods. Integrating qualitative self-report channels into digital interventions may enhance AE detection rates, improve clinical trial safety monitoring, and support post-market surveillance.
20 August 2025 in bioRxiv
Depression is neurobiologically and clinically heterogeneous. New approaches using resting-state functional MRI (rs-fMRI) functional connectivity (FC) data have modeled the neural basis of depression heterogeneity and revealed unique neural phenotypes. Yet, no studies have identified depression phenotypes from electrophysiological magnetoencephalography (MEG) data although MEG measures human brain dynamics at millisecond precision. We demonstrate here unique depression phenotypes based on MEG-oscillation FC. We collected resting-state MEG, MRI, and clinical symptom data from 263 patients with unipolar depression and 75 healthy controls. We assessed MEG-FC with two oscillatory coupling-mode measures that are fundamental for information processing. To define normative phenotypes, we computed their latent-space low-dimensional brain-symptom associations, and used these components to identify phenotypes using unsupervised machine learning. We identified five stable depression phenotypes that were characterized by unique symptom profiles and distinct spectral patterns. Our results demonstrate new neural underpinnings of depression heterogeneity and reveal unique neural phenotypes with potential personalized diagnostic value.
23 January 2026 in medRxiv
Major depressive disorder (MDD) is characterized by both physiological and psychological changes that impact daily function and quality of life. Despite advancements in treatment approaches, clinical outcomes remain variable, highlighting the need for reliable biomarkers to guide treatment selection and to monitor treatment responses. Transcranial magnetic stimulation combined with electroencephalography (TMS–EEG) allows for the characterization of local cortical excitation and inhibition through TMS-evoked potentials (TEPs). However, interindividual variability and various artifacts have previously limited the utility of TEPs for biomarker development. We applied single-pulse TMS to the left dorsolateral prefrontal cortex (L-DLPFC), and recorded EEG responses in 28 individuals with MDD and 8 healthy controls. An individualized mapping procedure identified stimulation sites and intensities that minimized artifacts and ensured early TEP (<60 ms) deflections exceeded the predefined threshold of 6 μV. We quantified the ratio between the second and first peak-to-peak amplitudes of the TEP, as excitatory and inhibitory mechanisms have been identified to contribute to these peaks. The TEP peak ratio differed significantly between MDD participants and healthy controls ( p = 0.003), and correlated with depression symptom severity quantified with the Quick Inventory of Depressive Symptomatology Self-Report ( r = 0.459, p < 0.05), Ruminative Response Scale ( r = 0.656, p < 0.001), Patient Health Questionnaire ( r = 0.368, p < 0.05), and Positive Valence Systems Scale ( r = 0.332, p < 0.05). These correlations were not observed when an anatomy-based targeting method (Beam F3) was applied with the conventional stimulation intensity of 120% of the resting motor threshold. Our findings highlight the utility of a novel individualised mapping technique in capturing high-quality early TEPs through a real-time EEG readout for minimisation of artifacts and ensuring a minimum TMS-evoked response. The altered TEP peak ratio adds to the growing body of evidence that the excitation/inhibition imbalance plays a role in MDD neurophysiology and serves as a promising candidate biomarker that warrants further investigation.
29 October 2026 in Imaging Neuroscience
Mechanistic neuroimaging-based biomarkers based on localized brain activities or interactions are central to precision and personalized psychiatry. However, their accuracy may be limited by Activity Mixing, a novel construct indicating the entanglement of local neuronal activity with distributed network activities through long-range spatiotemporal correlations, which degrades brain–symptom localization. As a solution to mitigate this inverse problem, we developed a multi-objective fitting approach integrating synchronization and criticality metrics to estimate subject-specific local- and inter-areal control parameters from neuroimaging observables. In silico validation showed that fitted parameters improved brain–symptom correlation estimates by 30–85% and reduced false-negative rates by ~67% relative to conventional analyses. As in vivo proof-of-concept, resting-state MEG data from 230 patients with major depressive disorder demonstrated that alpha-band (11 Hz) criticality predicted disability (r = 0.236), which improved to 0.368 after model fitting with narrower anatomical localization. These findings suggest that model fitting can mitigate the effects of activity mixing, providing subject-specific control-parameter estimates that delineate potential biomarkers for brain disorders more accurately than raw brain imaging observables.